Related Articles
Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited‑stage small‑cell lung cancer receiving concurrent chemoradiation of more than 45 Gy
Neurotoxicity due to prophylactic cranial irradiation for small‑cell lung cancer: A retrospective analysis
Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection
A meta‑analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited‑disease small‑cell lung cancer
The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance